Cargando…
MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade
Mitogen-activated protein kinase 6 (MAPK6) is an atypical MAPK. Its function in regulating cancer growth remains elusive. Here, we reported that MAPK6 directly activated AKT and induced oncogenic outcomes. MAPK6 interacted with AKT through its C34 region and the C-terminal tail and phosphorylated AK...
Autores principales: | Cai, Qinbo, Zhou, Wolong, Wang, Wei, Dong, Bingning, Han, Dong, Shen, Tao, Creighton, Chad J., Moore, David D., Yang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589317/ https://www.ncbi.nlm.nih.gov/pubmed/34767444 http://dx.doi.org/10.1126/sciadv.abi6439 |
Ejemplares similares
-
MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade
por: Wang, Wei, et al.
Publicado: (2022) -
A conserved long-distance telomeric silencing mechanism suppresses mTOR signaling in aging human fibroblasts
por: Jäger, Kathrin, et al.
Publicado: (2022) -
The 40S-LARP1 complex reprograms the cellular translatome upon mTOR inhibition to preserve the protein synthetic capacity
por: Fuentes, Pedro, et al.
Publicado: (2021) -
Glycogen synthase kinase 3 drives thymocyte egress by suppressing β-catenin activation of Akt
por: Liu, Chenfeng, et al.
Publicado: (2021) -
Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC
por: Boslem, Ebru, et al.
Publicado: (2023)